The CancerIQ product suite is an end-to-end solution, genetic history data gathering to supporting the management of high-risk care plans.
NCBC 2021: Breast centers expedited the adoption of virtual care to better serve high-risk patients missing appointments due to COVID-19.
Top takeaways from the ACCC 2021 Virtual meeting
Digital health innovation is messy, gritty, iterative, and most importantly, it takes place across the healthcare ecosystem.
President’s Cancer Panel: Why screening and testing are paramount as cancer diagnoses are down nearly 50% during the pandemic.
CancerIQ, an enterprise precision health platform for cancer, has formed a network of trusted genetic labs to streamline and inform the genetic test...
Community centers lose revenue potential from patient leakage, up to $650,000, on average, per patient. But what if there were a way to plug those...
Learn how to transition to telehealth and the steps Adventist's AHEAD Program took to achieve 133% of budgeted visit volume during the shutdowns.
In no other specialty is the evidence supporting Precision Health more clear than in Oncology. The result is early detection and the best possible...
Patient-centric best practices for operating genetics and high-risk cancer programs in the age of COVID-19.